|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 355 for C1qa

<< First    < Previous  |  Next >    Last >>
0.033s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
GXD Expression
GXD Expression
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:1736620
Pattern: Spotted
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7933
Note: single cell expression
Specimen Label: GUDMAP:7933
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:7332759
Assay Type: RNA in situ
Annotation Date: 2022-08-30
Strength: Present
Sex: Female
Emaps: EMAPS:2962120
Pattern: Regionally restricted
Stage: TS20
Assay Id: MGI:7332797
Age: embryonic day 12.5
Note: Expression is at the distal tip on either side of the distal urethral epithelium. There are no obvious differences between male and female expression patterns.
Specimen Label: 3A female
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:1736820
Pattern: Spotted
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7932
Note: single cell expression
Specimen Label: GUDMAP:7932
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:1736820
Pattern: Spotted
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7933
Note: single cell expression
Specimen Label: GUDMAP:7933
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:2890920
Pattern: Spotted
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7930
Note: single cell expression
Specimen Label: GUDMAP:7930
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:1796820
Pattern: Spotted
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7931
Note: single cell expression
Specimen Label: GUDMAP:7931
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:7332759
Assay Type: RNA in situ
Annotation Date: 2022-08-30
Strength: Present
Sex: Male
Emaps: EMAPS:2916720
Pattern: Regionally restricted
Stage: TS20
Assay Id: MGI:7332797
Age: embryonic day 12.5
Note: Expression is at the distal tip on either side of the distal urethral epithelium. There are no obvious differences between male and female expression patterns.
Specimen Label: 3A male
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:1927523
Assay Type: RNA in situ
Annotation Date: 2000-12-20
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1745921
Pattern: Regionally restricted
Stage: TS21
Assay Id: MGI:1927878
Age: embryonic day 13.5
Image: 5C
Note: Expression is in the macrophage clearance domain.
Specimen Label: 5C
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:1927523
Assay Type: RNA in situ
Annotation Date: 2000-12-20
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1745921
Stage: TS21
Assay Id: MGI:1927878
Age: embryonic day 13.5
Image: 5D
Specimen Label: 5D
Detected: false
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:2913820
Pattern: Spotted
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7931
Note: single cell expression
Specimen Label: GUDMAP:7931
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:2891420
Pattern: Spotted
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7930
Note: single cell expression
Specimen Label: GUDMAP:7930
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
   
Assay Type: In situ reporter (knock in)
Annotation Date: 2021-04-16
Strength: Present
Sex: Female
Emaps: EMAPS:1750328
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6692985
Age: postnatal adult
Image: JAX_1801077
Specimen Label: JAX_1801077
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Ambiguous
Sex: Male
Emaps: EMAPS:1797220
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7931
Note: signal appears restricted to the surface and may be associated mesentery
Specimen Label: GUDMAP:7931
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
   
Assay Type: In situ reporter (knock in)
Annotation Date: 2021-04-16
Strength: Present
Sex: Male
Emaps: EMAPS:1797228
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6692985
Age: postnatal adult
Image: JAX_1801080
Specimen Label: JAX_1801080
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Ambiguous
Sex: Female
Emaps: EMAPS:2891920
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7930
Specimen Label: GUDMAP:7930
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:2914320
Pattern: Spotted
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7931
Note: single cell expression
Specimen Label: GUDMAP:7931
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:3087020
Pattern: Spotted
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7932
Note: single cell expression
Specimen Label: GUDMAP:7932
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:3087020
Pattern: Spotted
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7933
Note: single cell expression
Specimen Label: GUDMAP:7933
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:7332759
Assay Type: RNA in situ
Annotation Date: 2022-08-30
Strength: Absent
Sex: Male
Emaps: EMAPS:2855520
Stage: TS20
Assay Id: MGI:7332797
Age: embryonic day 12.5
Specimen Label: 3A male
Detected: false
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:7332759
Assay Type: RNA in situ
Annotation Date: 2022-08-30
Strength: Absent
Sex: Female
Emaps: EMAPS:2855520
Stage: TS20
Assay Id: MGI:7332797
Age: embryonic day 12.5
Specimen Label: 3A female
Detected: false
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Ambiguous
Sex: Female
Emaps: EMAPS:2892420
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7930
Specimen Label: GUDMAP:7930
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:1406697
Assay Type: RNA in situ
Annotation Date: 2017-08-09
Strength: Present
Sex: Male
Emaps: EMAPS:3151020
Pattern: Graded
Stage: TS20
Assay Id: MGI:5906433
Age: embryonic day 12.5
Image: GUDMAP:21141
Specimen Label: GUDMAP:21141
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6168726
Assay Type: RNA in situ
Annotation Date: 2021-12-01
Strength: Present
Sex: Male
Emaps: EMAPS:3288723
Pattern: Single cells
Stage: TS23
Assay Id: MGI:6828831
Age: embryonic day 15.5
Image: 7 S1
Note: This is a macrophage marker.
Specimen Label: 7 S1
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:5000934
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Ambiguous
Sex: Female
Emaps: EMAPS:1796220
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:5541492
Age: embryonic day 12.5
Image: GUDMAP:7930
Note: signal on ovaries likely to be associated mesentery
Specimen Label: GUDMAP:7930
Specimen Num: 1
•
•
•
•
•
Publication
1940381 | J:1795
First Author: Petry F
Year: 1991
Journal: J Immunol
Title: Gene expression of the A- and B-chain of mouse C1q in different tissues and the characterization of the recombinant A-chain.
Volume: 147
Issue: 11
Pages: 3988-93
•
•
•
•
•
Publication
28407005 | J:245781
First Author: Panayiotou E
Year: 2017
Journal: PLoS One
Title: C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy.
Volume: 12
Issue: 4
Pages: e0175767
•
•
•
•
•
Publication
12930357 | J:85227
First Author: Robson MG
Year: 2003
Journal: Clin Exp Immunol
Title: Antibody-mediated glomerulonephritis in mice: the role of endotoxin, complement and genetic background.
Volume: 133
Issue: 3
Pages: 326-33
•
•
•
•
•
Publication
21688269 | J:177219
First Author: Cohen D
Year: 2011
Journal: J Pathol
Title: Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.
Volume: 225
Issue: 4
Pages: 502-11
•
•
•
•
•
Publication
21263075 | J:169405
First Author: Dahlke K
Year: 2011
Journal: J Immunol
Title: Distinct different contributions of the alternative and classical complement activation pathway for the innate host response during sepsis.
Volume: 186
Issue: 5
Pages: 3066-75
•
•
•
•
•
Publication
19783052 | J:155230
First Author: Lattin JE
Year: 2009
Journal: Mol Immunol
Title: Beta-arrestin 2 is required for complement C1q expression in macrophages and constrains factor-independent survival.
Volume: 47
Issue: 2-3
Pages: 340-7
•
•
•
•
•
Publication
28432146 | J:247864
First Author: Ho NI
Year: 2017
Journal: J Immunol
Title: C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes.
Volume: 198
Issue: 11
Pages: 4235-4243
•
•
•
•
•
Publication
15147568 | J:90499
First Author: Hutchinson WL
Year: 2004
Journal: Immunology
Title: Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice.
Volume: 112
Issue: 2
Pages: 250-4
•
•
•
•
•
Publication
25132557 | J:218316
 
First Author: Howell GR
Year: 2014
Journal: Neurobiol Dis
Title: Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma.
Volume: 71
Pages: 44-52
•
•
•
•
•
Publication
31484074 | J:284315
First Author: Hassan AO
Year: 2019
Journal: Cell Rep
Title: A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy.
Volume: 28
Issue: 10
Pages: 2634-2646.e4
•
•
•
•
•
Publication
24349316 | J:209864
First Author: Ali YM
Year: 2013
Journal: PLoS One
Title: Human L-ficolin, a recognition molecule of the lectin activation pathway of complement, activates complement by binding to pneumolysin, the major toxin of Streptococcus pneumoniae.
Volume: 8
Issue: 12
Pages: e82583
•
•
•
•
•
Publication
12432394 | J:85080
First Author: Garlanda C
Year: 2002
Journal: Nature
Title: Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response.
Volume: 420
Issue: 6912
Pages: 182-6
•
•
•
•
•
Publication
11283677 | J:125468
First Author: Mabbott NA
Year: 2001
Journal: Nat Med
Title: Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie.
Volume: 7
Issue: 4
Pages: 485-7
•
•
•
•
•
Publication
15322019 | J:92431
First Author: Windbichler M
Year: 2004
Journal: Infect Immun
Title: Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis.
Volume: 72
Issue: 9
Pages: 5247-52
•
•
•
•
•
Publication
21849679 | J:179233
First Author: Greenlee-Wacker MC
Year: 2011
Journal: J Immunol
Title: Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis.
Volume: 187
Issue: 6
Pages: 3353-61
•
•
•
•
•
Publication
8878426 | J:36093
First Author: Vyse TJ
Year: 1996
Journal: J Clin Invest
Title: Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice.
Volume: 98
Issue: 8
Pages: 1762-72
•
•
•
•
•
Publication
35115674 | J:322943
First Author: Kim ES
Year: 2022
Journal: Exp Mol Med
Title: Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q/TNF-related protein 9 genetic deficiency.
Volume: 54
Issue: 2
Pages: 103-114
•
•
•
•
•
Publication
37726739 | J:340750
First Author: Petrisko TJ
Year: 2023
Journal: J Neuroinflammation
Title: Influence of complement protein C1q or complement receptor C5aR1 on gut microbiota composition in wildtype and Alzheimer's mouse models.
Volume: 20
Issue: 1
Pages: 211
•
•
•
•
•
Publication
24334446 | J:229147
First Author: Murinello S
Year: 2014
Journal: Invest Ophthalmol Vis Sci
Title: Fcγ receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration.
Volume: 55
Issue: 1
Pages: 247-58
•
•
•
•
•
Publication
36972444 | J:353333
First Author: Chen X
Year: 2023
Journal: Proc Natl Acad Sci U S A
Title: Immunoglobulin G subclasses confer protection against Staphylococcus aureus bloodstream dissemination through distinct mechanisms in mouse models.
Volume: 120
Issue: 14
Pages: e2220765120
•
•
•
•
•
Publication
17121989 | J:118289
First Author: Urich E
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors.
Volume: 103
Issue: 49
Pages: 18697-702
•
•
•
•
•
Publication
17200212 | J:117210
First Author: Bhatia VK
Year: 2007
Journal: Am J Pathol
Title: Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice.
Volume: 170
Issue: 1
Pages: 416-26
•
•
•
•
•
Publication
19620499 | J:166420
First Author: Lewis MJ
Year: 2009
Journal: Circulation
Title: Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.
Volume: 120
Issue: 5
Pages: 417-26
•
•
•
•
•
Publication
22918632 | J:214061
First Author: Ding QJ
Year: 2012
Journal: Invest Ophthalmol Vis Sci
Title: Lack of immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma.
Volume: 53
Issue: 10
Pages: 6370-7
•
•
•
•
•
Publication
21502587 | J:173492
First Author: Li Q
Year: 2011
Journal: Infect Immun
Title: Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice.
Volume: 79
Issue: 7
Pages: 2578-85
•
•
•
•
•
Publication
11560991 | J:119459
First Author: Manderson AP
Year: 2001
Journal: J Exp Med
Title: Continual low-level activation of the classical complement pathway.
Volume: 194
Issue: 6
Pages: 747-56
•
•
•
•
•
Publication
25467802 | J:223071
First Author: Cresci GA
Year: 2015
Journal: Mol Immunol
Title: Alternative complement pathway component Factor D contributes to efficient clearance of tissue debris following acute CCl₄-induced injury.
Volume: 64
Issue: 1
Pages: 9-17
•
•
•
•
•
Publication
22679554 | J:336703
 
First Author: Michel B
Year: 2012
Journal: Sci Rep
Title: Incunabular immunological events in prion trafficking.
Volume: 2
Pages: 440
•
•
•
•
•
Publication
17237437 | J:143634
First Author: Rupprecht TA
Year: 2007
Journal: J Immunol
Title: Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system.
Volume: 178
Issue: 3
Pages: 1861-9
•
•
•
•
•
Publication
26773156 | J:323377
First Author: Carlucci F
Year: 2016
Journal: J Immunol
Title: C1q Modulates the Response to TLR7 Stimulation by Pristane-Primed Macrophages: Implications for Pristane-Induced Lupus.
Volume: 196
Issue: 4
Pages: 1488-94
•
•
•
•
•
Publication
20213737 | J:160952
First Author: Baruah P
Year: 2010
Journal: Eur J Immunol
Title: Mice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of tolerance.
Volume: 40
Issue: 6
Pages: 1758-67
•
•
•
•
•
Publication
12452836 | J:115531
First Author: Cortes-Hernandez J
Year: 2002
Journal: Clin Exp Immunol
Title: Murine glomerular mesangial cell uptake of apoptotic cells is inefficient and involves serum-mediated but complement-independent mechanisms.
Volume: 130
Issue: 3
Pages: 459-66
•
•
•
•
•
Publication
24170856 | J:202888
First Author: Lobsiger CS
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice.
Volume: 110
Issue: 46
Pages: E4385-92
•
•
•
•
•
Publication
34725868 | J:334033
First Author: Dahmani M
Year: 2021
Journal: Mol Microbiol
Title: Contribution of classical complement activation and IgM to the control of Rickettsia infection.
Volume: 116
Issue: 6
Pages: 1476-1488
•
•
•
•
•
Publication
24381160 | J:206365
First Author: Woodruff TM
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Role for terminal complement activation in amyotrophic lateral sclerosis disease progression.
Volume: 111
Issue: 1
Pages: E3-4
•
•
•
•
•
Publication
27876407 | J:240044
First Author: Giacomassi C
Year: 2017
Journal: J Invest Dermatol
Title: Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform Dermatitis.
Volume: 137
Issue: 3
Pages: 760-763
•
•
•
•
•
Publication
12244199 | J:120404
First Author: Vandivier RW
Year: 2002
Journal: J Immunol
Title: Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex.
Volume: 169
Issue: 7
Pages: 3978-86
•
•
•
•
•
Publication
21235806 | J:194454
First Author: Fonseca MI
Year: 2011
Journal: J Neuroinflammation
Title: Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease.
Volume: 8
Issue: 1
Pages: 4
•
•
•
•
•
Publication
22721768 | J:187183
First Author: Berg A
Year: 2012
Journal: Exp Neurol
Title: Reduced removal of synaptic terminals from axotomized spinal motoneurons in the absence of complement C3.
Volume: 237
Issue: 1
Pages: 8-17
•
•
•
•
•
Publication
29724957 | J:263219
First Author: Ling GS
Year: 2018
Journal: Science
Title: C1q restrains autoimmunity and viral infection by regulating CD8+ T cell metabolism.
Volume: 360
Issue: 6388
Pages: 558-563
•
•
•
•
•
Publication
11359841 | J:69479
First Author: Robson MG
Year: 2001
Journal: J Immunol
Title: Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.
Volume: 166
Issue: 11
Pages: 6820-8
•
•
•
•
•
Publication
10229798 | J:54978
First Author: Mitchell DA
Year: 1999
Journal: J Immunol
Title: Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation.
Volume: 162
Issue: 10
Pages: 5676-9
•
•
•
•
•
Publication
27304426 | J:252885
First Author: Wang Y
Year: 2016
Journal: PLoS Pathog
Title: Bacillus anthracis Spore Surface Protein BclA Mediates Complement Factor H Binding to Spores and Promotes Spore Persistence.
Volume: 12
Issue: 6
Pages: e1005678
•
•
•
•
•
Publication
38942014 | J:351466
     
First Author: Scott-Hewitt N
Year: 2024
Journal: Cell
Title: Microglial-derived C1q integrates into neuronal ribonucleoprotein complexes and impacts protein homeostasis in the aging brain.
•
•
•
•
•
Publication
14971048 | J:89254
First Author: Yamada M
Year: 2004
Journal: Eur J Immunol
Title: Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells.
Volume: 34
Issue: 1
Pages: 221-30
•
•
•
•
•
Publication
26631482 | J:230898
First Author: Kim C
Year: 2016
Journal: FASEB J
Title: The alternative complement pathway aids in vascular regression during the early stages of a murine model of proliferative retinopathy.
Volume: 30
Issue: 3
Pages: 1300-5
•
•
•
•
•
Publication
19171874 | J:148297
First Author: Baruah P
Year: 2009
Journal: Blood
Title: C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells.
Volume: 113
Issue: 15
Pages: 3485-93
•
•
•
•
•
Publication
18624920 | J:138852
First Author: Zhou J
Year: 2008
Journal: J Neurochem
Title: Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.
Volume: 106
Issue: 5
Pages: 2080-92
•
•
•
•
•
Publication
15749852 | J:97686
First Author: Stuart LM
Year: 2005
Journal: J Immunol
Title: Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype.
Volume: 174
Issue: 6
Pages: 3220-6
•
•
•
•
•
Publication
17114482 | J:140685
First Author: Chan RK
Year: 2006
Journal: J Immunol
Title: The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion.
Volume: 177
Issue: 11
Pages: 8080-5
•
•
•
•
•
Publication
34762332 | J:320664
First Author: Cong Q
Year: 2022
Journal: Glia
Title: C1q and SRPX2 regulate microglia mediated synapse elimination during early development in the visual thalamus but not the visual cortex.
Volume: 70
Issue: 3
Pages: 451-465
•
•
•
•
•
Publication
30652266 | J:284871
First Author: Bie B
Year: 2019
Journal: Mol Neurobiol
Title: Activation of mGluR1 Mediates C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer's Rodent Models.
Volume: 56
Issue: 8
Pages: 5568-5585
•
•
•
•
•
Publication
24945405 | J:246764
First Author: Sharif O
Year: 2014
Journal: PLoS Pathog
Title: The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia.
Volume: 10
Issue: 6
Pages: e1004167
•
•
•
•
•
Publication
33323383 | J:305590
First Author: Markarian M
Year: 2021
Journal: Cancer Res
Title: Glia-Selective Deletion of Complement C1q Prevents Radiation-Induced Cognitive Deficits and Neuroinflammation.
Volume: 81
Issue: 7
Pages: 1732-1744
•
•
•
•
•
Publication
38089576 | J:343203
First Author: Yu Q
Year: 2023
Journal: iScience
Title: C1q is essential for myelination in the central nervous system (CNS).
Volume: 26
Issue: 12
Pages: 108518
•
•
•
•
•
Publication
33628204 | J:346424
 
First Author: Kovács RÁ
Year: 2020
Journal: Front Immunol
Title: Identification of Neuronal Pentraxins as Synaptic Binding Partners of C1q and the Involvement of NP1 in Synaptic Pruning in Adult Mice.
Volume: 11
Pages: 599771
•
•
•
•
•
Publication
22262892 | J:179890
First Author: Linnartz B
Year: 2012
Journal: J Neurosci
Title: Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microglia.
Volume: 32
Issue: 3
Pages: 946-52
•
•
•
•
•
Publication
35167491 | J:327263
 
First Author: Tsao LC
Year: 2022
Journal: JCI Insight
Title: Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis.
Volume: 7
Issue: 6
•
•
•
•
•
Publication
11901193 | J:75709
First Author: Azeredo da Silveira S
Year: 2002
Journal: J Exp Med
Title: Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody.
Volume: 195
Issue: 6
Pages: 665-72
•
•
•
•
•
Publication
20810984 | J:164313
First Author: Renner B
Year: 2010
Journal: J Immunol
Title: B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion.
Volume: 185
Issue: 7
Pages: 4393-400
•
•
•
•
•
Publication
19458267 | J:152584
First Author: Woodman ME
Year: 2009
Journal: J Leukoc Biol
Title: Roles for phagocytic cells and complement in controlling relapsing fever infection.
Volume: 86
Issue: 3
Pages: 727-36
•
•
•
•
•
Publication
38696270 | J:361328
First Author: Eddens T
Year: 2024
Journal: Am J Respir Cell Mol Biol
Title: Monocyte Production of C1q Potentiates CD8(+) T-Cell Function Following Respiratory Viral Infection.
Volume: 71
Issue: 3
Pages: 294-306
•
•
•
•
•
Publication
16982912 | J:139312
First Author: Zhang M
Year: 2006
Journal: J Immunol
Title: Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury.
Volume: 177
Issue: 7
Pages: 4727-34
•
•
•
•
•
Publication
29941548 | J:265683
First Author: Norris GT
Year: 2018
Journal: J Exp Med
Title: Neuronal integrity and complement control synaptic material clearance by microglia after CNS injury.
Volume: 215
Issue: 7
Pages: 1789-1801
•
•
•
•
•
Publication
16034123 | J:107276
First Author: Yuste J
Year: 2005
Journal: J Immunol
Title: Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia.
Volume: 175
Issue: 3
Pages: 1813-9
•
•
•
•
•
Publication
22457620 | J:195398
First Author: Gunn BM
Year: 2012
Journal: PLoS Pathog
Title: Mannose binding lectin is required for alphavirus-induced arthritis/myositis.
Volume: 8
Issue: 3
Pages: e1002586
•
•
•
•
•
Publication
21257205 | J:174154
First Author: Rohrer B
Year: 2011
Journal: Mol Immunol
Title: The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization.
Volume: 48
Issue: 6-7
Pages: e1-8
•
•
•
•
•
Publication
16670320 | J:131701
First Author: Yuste J
Year: 2006
Journal: J Immunol
Title: Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes.
Volume: 176
Issue: 10
Pages: 6112-20
•
•
•
•
•
Publication
17475881 | J:146108
First Author: Mihai S
Year: 2007
Journal: J Immunol
Title: The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.
Volume: 178
Issue: 10
Pages: 6514-21
•
•
•
•
•
Publication
23028050 | J:190597
First Author: Elvington A
Year: 2012
Journal: J Immunol
Title: The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.
Volume: 189
Issue: 9
Pages: 4640-7
•
•
•
•
•
Publication
17675237 | J:125347
First Author: Giacomin PR
Year: 2008
Journal: Mol Immunol
Title: The role of complement in innate, adaptive and eosinophil-dependent immunity to the nematode Nippostrongylus brasiliensis.
Volume: 45
Issue: 2
Pages: 446-55
•
•
•
•
•
Publication
10934224 | J:63875
First Author: Taylor PR
Year: 2000
Journal: J Exp Med
Title: A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.
Volume: 192
Issue: 3
Pages: 359-66
•
•
•
•
•
Publication
16778128 | J:123658
First Author: Mocco J
Year: 2006
Journal: Circ Res
Title: Complement component C3 mediates inflammatory injury following focal cerebral ischemia.
Volume: 99
Issue: 2
Pages: 209-17
•
•
•
•
•
Publication
34417332 | J:336669
First Author: Peterson SL
Year: 2021
Journal: J Neurosci
Title: Retinal Ganglion Cell Axon Regeneration Requires Complement and Myeloid Cell Activity within the Optic Nerve.
Volume: 41
Issue: 41
Pages: 8508-8531
•
•
•
•
•
Publication
28710441 | J:253722
First Author: Zhang L
Year: 2017
Journal: Sci Rep
Title: IgG3-antigen complexes are deposited on follicular dendritic cells in the presence of C1q and C3.
Volume: 7
Issue: 1
Pages: 5400
•
•
•
•
•
Publication
22427639 | J:184059
First Author: Link A
Year: 2012
Journal: J Immunol
Title: Innate immunity mediates follicular transport of particulate but not soluble protein antigen.
Volume: 188
Issue: 8
Pages: 3724-33
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom